About me
Dr. Sara Kenkare-Mitra, Ph.D., is a seasoned biotech/pharma drug developer, scientist and executive, currently serving as the President and Head of Research and Development at Alector since 2021. With over 25 years of industry experience, she has dedicated her career to developing novel drugs and personalizing treatments. Dr. Kenkare-Mitra’s work spans the entire drug discovery and development spectrum, including the successful global filing and launch of multiple drugs during her 24-year tenure at Genentech/Roche. Her academic qualifications include a Ph.D. in Pharmaceutical Chemistry from the University of California, San Francsico (UCSF), a Fellowship in Clinical Pharmacology, and post-doctoral training at UCSF.